Enhanced deposition of predominantly type I collagen in myocardial disease.
about
Physiological Implications of Myocardial Scar StructureDifferent microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy studyIntramyocardial fibroblast myocyte communication.Structural remodelling of the sinoatrial node in obese old rats.Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population.Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.Collagen network remodelling and left ventricular function in constrictive pericarditis.A post-MI power struggle: adaptations in cardiac power occur at the sarcomere level alongside MyBP-C and RLC phosphorylationCoronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy.Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro.D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice.Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the rat alpha 1(I) collagen promoter specifically inhibits factor binding and transcription.SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis.Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy.Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy.Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.Mechanical load and polypeptide growth factors stimulate cardiac fibroblast activity.Collagen remodeling after myocardial infarction in the rat heartEffect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin.Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.In Vivo Quantification of Myocardial Infarction in Mice Using Micro-CT and a Novel Blood Pool Agent.Ventricular remodeling and the renin angiotensin aldosterone system.Fibrotic infarction on the LV free wall may alter the mechanics of healthy septal wall during passive filling.Native T1 value in the remote myocardium is independently associated with left ventricular dysfunction in patients with prior myocardial infarction.Increased myocardial expression of osteopontin in patients with advanced heart failure.Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice
P2860
Q28085424-7423DD4E-8114-43FF-B57C-08761184A8B1Q30755828-E7DF4D92-8D7C-4684-B284-743229E006CCQ33586605-833EE691-0179-401C-B967-F76D2FBC5F3DQ33754290-FC4D5193-A7A7-41E6-AF6B-B9BF10B46C8AQ34652219-F0E6933B-9061-4EBA-B414-575C3903CEA3Q34846884-7275ECFF-F66B-44FC-91D5-B945B7A69EB0Q36222011-8A86C1ED-96BE-4EAF-8CA4-DB8DD662C527Q36544287-903138E9-CF41-4DD5-A96F-AC2057E0F74EQ36829567-1B6A0E49-2C94-43AD-8979-3D1F42FBAA29Q37218043-1172810B-3610-4E74-850B-3EDC47FFDB7FQ37325205-B1CA8B04-DF8E-42E0-BB20-8BA482CDFA41Q37341418-10017E90-26EB-43AE-A13F-73DD956F9BFAQ37631229-FB7AFFE7-F4F3-442B-84EF-E8DFE3285803Q38174997-4A2BAD20-B044-4E40-BE5D-978EF446343EQ38362630-1456ECFC-1F20-48D5-A146-70D62D20BB2AQ38859940-382B1F4B-5058-4F39-9F06-03844BE0500DQ38983404-66C77A48-0B94-40E1-89F7-5E93ADB84D89Q39726169-8734A388-5FA6-4A8B-82E2-5A9CEF699DEBQ40168710-166CCF3B-296A-4E15-B8CA-0A58451C2C86Q40528495-CE7B0EA3-054D-4E96-96F0-50728860A137Q41910646-25345FF2-45C6-4E3D-95BA-2CB97C1B0AC6Q42816496-AFAF6C13-4387-4B34-926C-69F3C56349AEQ43053682-279B637C-254A-4744-B527-3CA4BAD1D56BQ43626178-8C14EA8A-299C-4ECE-8DEB-80040988AB0EQ44109931-C12CBC1E-A40F-48BE-9686-8C4BD00B3FB7Q46475578-3FE3C450-9485-4E52-A25E-48480D942FA0Q50916534-A18D48A7-B5C1-4A31-930D-1B3FEB11A3D6Q52042603-BE6D33E5-0248-43EA-A777-5B55717980F6Q52563144-9F028C43-8D8A-4D10-B79D-901BA8446506Q59126955-C9629C24-7D35-4566-8221-FC4482CD1EA3
P2860
Enhanced deposition of predominantly type I collagen in myocardial disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Enhanced deposition of predominantly type I collagen in myocardial disease.
@en
Enhanced deposition of predominantly type I collagen in myocardial disease.
@nl
type
label
Enhanced deposition of predominantly type I collagen in myocardial disease.
@en
Enhanced deposition of predominantly type I collagen in myocardial disease.
@nl
prefLabel
Enhanced deposition of predominantly type I collagen in myocardial disease.
@en
Enhanced deposition of predominantly type I collagen in myocardial disease.
@nl
P2093
P1476
Enhanced deposition of predominantly type I collagen in myocardial disease.
@en
P2093
P304
P356
10.1016/0022-2828(90)90079-H
P577
1990-10-01T00:00:00Z